Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride for prevention of Double J stent encrustation
IRCT20190624043991N34Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of finasteride in ureteral stent encrustation (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Double J stent encrustation grade after removal. Started Feb 2026; status: completed.
02
Drugs
finasteride
03
Conditions
ureteral stent encrustation
Beyond the preview
Go deeper on IRCT20190624043991N34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190624043991N34.